The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Mumps Drug-Global Market Insights and Sales Trends 2025
Synopsis
The global Mumps Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Mumps Drug in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Mumps Drug market. RIT 4385, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Schwarz segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mumps Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Mumps Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Mumps Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mumps Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Mumps Drug covered in this report include Beijing Minhai Biotechnology Co., Ltd, Beijing Tiantan Biological Products Co., Ltd., China National Pharmaceutical Group Corporation, GlaxoSmithKline Plc, Organic Vaccines, Prometheon Pharma, LLC, Sinovac Biotech Ltd. and Zydus Cadila Healthcare Limited, etc.
The global Mumps Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Beijing Minhai Biotechnology Co., Ltd
Beijing Tiantan Biological Products Co., Ltd.
China National Pharmaceutical Group Corporation
GlaxoSmithKline Plc
Organic Vaccines
Prometheon Pharma, LLC
Sinovac Biotech Ltd.
Zydus Cadila Healthcare Limited
Global Mumps Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mumps Drug market, Segment by Type:
RIT 4385
Schwarz
Wistar RA 27/3
Others
Global Mumps Drug market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Mumps Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Mumps Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Mumps Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Mumps Drug in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Mumps Drug market. RIT 4385, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Schwarz segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mumps Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Mumps Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Mumps Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mumps Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Mumps Drug covered in this report include Beijing Minhai Biotechnology Co., Ltd, Beijing Tiantan Biological Products Co., Ltd., China National Pharmaceutical Group Corporation, GlaxoSmithKline Plc, Organic Vaccines, Prometheon Pharma, LLC, Sinovac Biotech Ltd. and Zydus Cadila Healthcare Limited, etc.
The global Mumps Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Beijing Minhai Biotechnology Co., Ltd
Beijing Tiantan Biological Products Co., Ltd.
China National Pharmaceutical Group Corporation
GlaxoSmithKline Plc
Organic Vaccines
Prometheon Pharma, LLC
Sinovac Biotech Ltd.
Zydus Cadila Healthcare Limited
Global Mumps Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mumps Drug market, Segment by Type:
RIT 4385
Schwarz
Wistar RA 27/3
Others
Global Mumps Drug market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Mumps Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Mumps Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Mumps Drug Market Overview
1.1 Mumps Drug Product Overview
1.2 Mumps Drug Market Segment by Type
1.2.1 RIT 4385
1.2.2 Schwarz
1.2.3 Wistar RA 27/3
1.2.4 Others
1.3 Global Mumps Drug Market Size by Type
1.3.1 Global Mumps Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Mumps Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global Mumps Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Mumps Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe Mumps Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Mumps Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Mumps Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Mumps Drug Sales Breakdown by Type (2018-2023)
2 Global Mumps Drug Market Competition by Company
2.1 Global Top Players by Mumps Drug Sales (2018-2023)
2.2 Global Top Players by Mumps Drug Revenue (2018-2023)
2.3 Global Top Players by Mumps Drug Price (2018-2023)
2.4 Global Top Manufacturers Mumps Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Mumps Drug Market Competitive Situation and Trends
2.5.1 Mumps Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Mumps Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mumps Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Mumps Drug Market
2.8 Key Manufacturers Mumps Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Mumps Drug Status and Outlook by Region
3.1 Global Mumps Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Mumps Drug Historic Market Size by Region
3.2.1 Global Mumps Drug Sales in Volume by Region (2018-2023)
3.2.2 Global Mumps Drug Sales in Value by Region (2018-2023)
3.2.3 Global Mumps Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Mumps Drug Forecasted Market Size by Region
3.3.1 Global Mumps Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Mumps Drug Sales in Value by Region (2024-2029)
3.3.3 Global Mumps Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Mumps Drug by Application
4.1 Mumps Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Mumps Drug Market Size by Application
4.2.1 Global Mumps Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Mumps Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global Mumps Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Mumps Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe Mumps Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Mumps Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Mumps Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Mumps Drug Sales Breakdown by Application (2018-2023)
5 North America Mumps Drug by Country
5.1 North America Mumps Drug Historic Market Size by Country
5.1.1 North America Mumps Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Mumps Drug Sales in Volume by Country (2018-2023)
5.1.3 North America Mumps Drug Sales in Value by Country (2018-2023)
5.2 North America Mumps Drug Forecasted Market Size by Country
5.2.1 North America Mumps Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Mumps Drug Sales in Value by Country (2024-2029)
6 Europe Mumps Drug by Country
6.1 Europe Mumps Drug Historic Market Size by Country
6.1.1 Europe Mumps Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Mumps Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe Mumps Drug Sales in Value by Country (2018-2023)
6.2 Europe Mumps Drug Forecasted Market Size by Country
6.2.1 Europe Mumps Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Mumps Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Mumps Drug by Region
7.1 Asia-Pacific Mumps Drug Historic Market Size by Region
7.1.1 Asia-Pacific Mumps Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Mumps Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Mumps Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Mumps Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Mumps Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Mumps Drug Sales in Value by Region (2024-2029)
8 Latin America Mumps Drug by Country
8.1 Latin America Mumps Drug Historic Market Size by Country
8.1.1 Latin America Mumps Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Mumps Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America Mumps Drug Sales in Value by Country (2018-2023)
8.2 Latin America Mumps Drug Forecasted Market Size by Country
8.2.1 Latin America Mumps Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Mumps Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Mumps Drug by Country
9.1 Middle East and Africa Mumps Drug Historic Market Size by Country
9.1.1 Middle East and Africa Mumps Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Mumps Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Mumps Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Mumps Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Mumps Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Mumps Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Beijing Minhai Biotechnology Co., Ltd
10.1.1 Beijing Minhai Biotechnology Co., Ltd Company Information
10.1.2 Beijing Minhai Biotechnology Co., Ltd Introduction and Business Overview
10.1.3 Beijing Minhai Biotechnology Co., Ltd Mumps Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Beijing Minhai Biotechnology Co., Ltd Mumps Drug Products Offered
10.1.5 Beijing Minhai Biotechnology Co., Ltd Recent Development
10.2 Beijing Tiantan Biological Products Co., Ltd.
10.2.1 Beijing Tiantan Biological Products Co., Ltd. Company Information
10.2.2 Beijing Tiantan Biological Products Co., Ltd. Introduction and Business Overview
10.2.3 Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Products Offered
10.2.5 Beijing Tiantan Biological Products Co., Ltd. Recent Development
10.3 China National Pharmaceutical Group Corporation
10.3.1 China National Pharmaceutical Group Corporation Company Information
10.3.2 China National Pharmaceutical Group Corporation Introduction and Business Overview
10.3.3 China National Pharmaceutical Group Corporation Mumps Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 China National Pharmaceutical Group Corporation Mumps Drug Products Offered
10.3.5 China National Pharmaceutical Group Corporation Recent Development
10.4 GlaxoSmithKline Plc
10.4.1 GlaxoSmithKline Plc Company Information
10.4.2 GlaxoSmithKline Plc Introduction and Business Overview
10.4.3 GlaxoSmithKline Plc Mumps Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 GlaxoSmithKline Plc Mumps Drug Products Offered
10.4.5 GlaxoSmithKline Plc Recent Development
10.5 Organic Vaccines
10.5.1 Organic Vaccines Company Information
10.5.2 Organic Vaccines Introduction and Business Overview
10.5.3 Organic Vaccines Mumps Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Organic Vaccines Mumps Drug Products Offered
10.5.5 Organic Vaccines Recent Development
10.6 Prometheon Pharma, LLC
10.6.1 Prometheon Pharma, LLC Company Information
10.6.2 Prometheon Pharma, LLC Introduction and Business Overview
10.6.3 Prometheon Pharma, LLC Mumps Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Prometheon Pharma, LLC Mumps Drug Products Offered
10.6.5 Prometheon Pharma, LLC Recent Development
10.7 Sinovac Biotech Ltd.
10.7.1 Sinovac Biotech Ltd. Company Information
10.7.2 Sinovac Biotech Ltd. Introduction and Business Overview
10.7.3 Sinovac Biotech Ltd. Mumps Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sinovac Biotech Ltd. Mumps Drug Products Offered
10.7.5 Sinovac Biotech Ltd. Recent Development
10.8 Zydus Cadila Healthcare Limited
10.8.1 Zydus Cadila Healthcare Limited Company Information
10.8.2 Zydus Cadila Healthcare Limited Introduction and Business Overview
10.8.3 Zydus Cadila Healthcare Limited Mumps Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Zydus Cadila Healthcare Limited Mumps Drug Products Offered
10.8.5 Zydus Cadila Healthcare Limited Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Mumps Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Mumps Drug Industrial Chain Analysis
11.4 Mumps Drug Market Dynamics
11.4.1 Mumps Drug Industry Trends
11.4.2 Mumps Drug Market Drivers
11.4.3 Mumps Drug Market Challenges
11.4.4 Mumps Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Mumps Drug Distributors
12.3 Mumps Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
